Investigational Drug Information for Ecgonine
✉ Email this page to a colleague
What is the development status for investigational drug Ecgonine?
Ecgonine is an investigational drug.
There have been 5 clinical trials for Ecgonine.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.
The most common disease conditions in clinical trials are Cocaine-Related Disorders, Substance-Related Disorders, and Renal Insufficiency. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Baylor College of Medicine, and Johns Hopkins University.
Summary for Ecgonine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,040 |
| WIPO Patent Applications | 391 |
| Japanese Patent Applications | 104 |
| Clinical Trial Progress | Phase 2 (2013-04-01) |
| Vendors | 13 |
Recent Clinical Trials for Ecgonine
| Title | Sponsor | Phase |
|---|---|---|
| PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function | Cognitive Research Corporation | Phase 1 |
| PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function | Pharmaceutical Project Solutions, Inc. | Phase 1 |
| A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse | Indivior Inc. | Phase 2 |
Clinical Trial Summary for Ecgonine
Top disease conditions for Ecgonine
Top clinical trial sponsors for Ecgonine
US Patents for Ecgonine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
